June 9, 2025 – A knowledge-based company specializing in advanced wound care dressings has developed an innovative, fully natural rapid hemostatic product derived from plant starch. According to Ali Sanjari, Clinical Director at Trita Company, their products are designed for a broad range of acute and chronic wound healing applications, including pressure ulcers, post-surgical wounds, and diabetic ulcers.

The company’s latest innovation, a plant-starch-based surgical hemostat, was officially unveiled at this year’s Iran Health Exhibition. This 100% absorbable product can be used across various surgical procedures and is entirely indigenized, with all technical knowledge and production technology developed by the company’s own experts.

Sanjari highlighted that the Iran Health Exhibition offers valuable B2B opportunities, and Trita is actively seeking to expand commercial partnerships. The company has already held several meetings with foreign firms from China, Pakistan, and Afghanistan, anticipating a promising outlook for export growth.

The 26th Iran Health Exhibition, with participation from 580 domestic and international companies, 45 specialized meetings and side events, and a dedicated pavilion for returning Iranian professionals, is taking place from June 8 to 11, 2025, at the Iran International Exhibition Center in Tehran.